FR2579893B1 - - Google Patents

Info

Publication number
FR2579893B1
FR2579893B1 FR868604772A FR8604772A FR2579893B1 FR 2579893 B1 FR2579893 B1 FR 2579893B1 FR 868604772 A FR868604772 A FR 868604772A FR 8604772 A FR8604772 A FR 8604772A FR 2579893 B1 FR2579893 B1 FR 2579893B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR868604772A
Other versions
FR2579893A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poli Industria Chimica SpA
Original Assignee
Poli Industria Chimica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Industria Chimica SpA filed Critical Poli Industria Chimica SpA
Publication of FR2579893A1 publication Critical patent/FR2579893A1/fr
Application granted granted Critical
Publication of FR2579893B1 publication Critical patent/FR2579893B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
FR868604772A 1985-04-04 1986-04-03 Expired - Lifetime FR2579893B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20234/85A IT1200603B (it) 1985-04-04 1985-04-04 Composizione farmaceutiche ad attivita dopaminergica

Publications (2)

Publication Number Publication Date
FR2579893A1 FR2579893A1 (fr) 1986-10-10
FR2579893B1 true FR2579893B1 (fr) 1991-07-05

Family

ID=11164998

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868604772A Expired - Lifetime FR2579893B1 (fr) 1985-04-04 1986-04-03

Country Status (6)

Country Link
US (1) US4673681A (fr)
JP (1) JPS61257922A (fr)
DE (1) DE3525390A1 (fr)
FR (1) FR2579893B1 (fr)
GB (1) GB2173101B (fr)
IT (1) IT1200603B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245369B (it) * 1991-03-28 1994-09-20 Poli Ind Chimica Spa Medicamento contenente alfa-diidroergocriptina ad azione neuroprotettrice
IT1252163B (it) * 1991-12-03 1995-06-05 Poli Ind Chimica Spa Composizioni farmaceutiche per la neuroprotezione nelle malattie neurologiche di carattere degenerativo o su base ischemica
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
ITMI20041855A1 (it) * 2004-09-29 2004-12-29 Polichem Sa Composizioni farmaceutiche di alfa-diidroergocriptina per uso transdermico e-o transmucoso.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
NL7314066A (fr) * 1972-10-18 1974-04-22
DE3043210A1 (de) * 1979-11-27 1981-08-27 Sandoz-Patent-GmbH, 7850 Lörrach Ergolinderivate, verfahren zu deren herstellung, diese enthaltende pharmazeutische zusammensetzungen und ihre anwendung bei der therapeutischen behandlung

Also Published As

Publication number Publication date
IT1200603B (it) 1989-01-27
DE3525390A1 (de) 1986-10-09
IT8520234A0 (it) 1985-04-04
JPH0415767B2 (fr) 1992-03-19
JPS61257922A (ja) 1986-11-15
GB8607848D0 (en) 1986-04-30
DE3525390C2 (fr) 1988-07-28
FR2579893A1 (fr) 1986-10-10
US4673681A (en) 1987-06-16
GB2173101B (en) 1989-09-20
GB2173101A (en) 1986-10-08

Similar Documents

Publication Publication Date Title
AU549439B2 (fr)
AU4708385A (fr)
BA96126A (fr)
AU3954685A (fr)
AU4121285A (fr)
BG44671A1 (fr)
BG45386A3 (fr)
AU8658089A (fr)
BG44810A1 (fr)
BE901679A (fr)
BE902936A (fr)
BE905108A (fr)
BG39572A1 (fr)
BG40852A1 (fr)
BG44563A1 (fr)
BG44571A1 (fr)
BG44572A1 (fr)
BG45212A3 (fr)
BG44609A1 (fr)
BG44643A1 (fr)
BG44654A1 (fr)
BG44657A1 (fr)
BG44878A3 (fr)
BG44667A1 (fr)
BG45195A1 (fr)

Legal Events

Date Code Title Description
TP Transmission of property